Aehr Test Systems, Inc. (AEHR)
NASDAQ: AEHR · Real-Time Price · USD
25.15
-0.04 (-0.16%)
Sep 9, 2025, 1:01 PM - Market open
Aehr Test Systems Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aehr Test Systems.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Aehr Test Systems.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades $12 | Strong Buy → Hold | Downgrades | $12 | -52.29% | Mar 26, 2024 |
William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2024 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 17, 2022 |
Financial Forecast
Revenue This Year
62.59M
from 58.97M
Increased by 6.13%
Revenue Next Year
83.56M
from 62.59M
Increased by 33.51%
EPS This Year
0.08
from -0.13
EPS Next Year
0.31
from 0.08
Increased by 281.25%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 | 2028 |
---|---|---|---|
High | 67.7M | 93.6M | |
Avg | 62.6M | 83.6M | |
Low | 54.6M | 73.3M |
Revenue Growth
Revenue Growth | 2026 | 2027 | 2028 |
---|---|---|---|
High | 14.8% | 49.5% | |
Avg | 6.1% | 33.5% | |
Low | -7.4% | 17.2% |
EPS Forecast
EPS | 2026 | 2027 | 2028 |
---|---|---|---|
High | 0.11 | 0.48 | |
Avg | 0.08 | 0.31 | |
Low | 0.06 | 0.15 |
EPS Growth
EPS Growth | 2026 | 2027 | 2028 |
---|---|---|---|
High | - | 491.9% | |
Avg | - | 281.2% | |
Low | - | 80.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.